COVID-19, Mental Health, and Chronic Illnesses: A Syndemic Perspective
Overview
Public Health
Affiliations
Background: The COVID-19 pandemic is an epidemiological and psychological crisis; what it does to the body is quite well known by now, and more research is underway, but the syndemic impact of COVID-19 and mental health on underlying chronic illnesses among the general population is not completely understood.
Methods: We carried out a literature review to identify the potential impact of COVID-19 and related mental health issues on underlying comorbidities that could affect the overall health of the population.
Results: Many available studies have highlighted the impact of COVID-19 on mental health only, but how complex their interaction is in patients with comorbidities and COVID-19, the absolute risks, and how they connect with the interrelated risks in the general population, remain unknown. The COVID-19 pandemic can be recognized as a syndemic due to; synergistic interactions among different diseases and other health conditions, increasing overall illness burden, emergence, spread, and interactions between infectious zoonotic diseases leading to new infectious zoonotic diseases; this is together with social and health interactions leading to increased risks in vulnerable populations and exacerbating clustering of multiple diseases.
Conclusion: There is a need to develop evidence to support appropriate and effective interventions for the overall improvement of health and psychosocial wellbeing of at-risk populations during this pandemic. The syndemic framework is an important framework that can be used to investigate and examine the potential benefits and impact of codesigning COVID-19/non-communicable diseases (NCDs)/mental health programming services which can tackle these epidemics concurrently.
De Ridder D, Uppal A, Rouzinov S, Lamour J, Zaballa M, Baysson H Int J Environ Res Public Health. 2025; 22(2).
PMID: 40003393 PMC: 11855532. DOI: 10.3390/ijerph22020166.
Conceptualizing COVID-19 syndemics: A scoping review.
Bulled N, Singer M J Multimorb Comorb. 2024; 14:26335565241249835.
PMID: 38682155 PMC: 11055430. DOI: 10.1177/26335565241249835.
Raile P F1000Res. 2024; 12:982.
PMID: 38628975 PMC: 11019290. DOI: 10.12688/f1000research.139879.2.
Silva M, Sotelo G, Fernandes F, Valentim L, Paula M, Quaresma T Pharmaceuticals (Basel). 2024; 17(3).
PMID: 38543090 PMC: 10975161. DOI: 10.3390/ph17030304.
Armaou M, Pears M, Konstantinidis S, Blake H Int J Environ Res Public Health. 2024; 21(3).
PMID: 38541374 PMC: 10970530. DOI: 10.3390/ijerph21030375.